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Summary
Objective: Autologous chondrocyte implantation (ACI) has been successfully used for the treatment of osteochondral lesions of the talus. One
of the main problems of this surgical strategy is related to the harvesting of the cartilage slice from a healthy knee. The aim of this study was to
examine the capacity of chondrocytes harvested from a detached osteochondral fragment to proliferate and to serve as a source of viable cells
for ACI in the repair of ankle cartilage defects.
Methods: Detached osteochondral fragments harvested from the ankle joint of 20 patients with osteochondral lesions of the talus served as
the source of human articular cartilage specimens. All of the osteochondral lesions were chronic and of traumatic origin. In all cases, the
fragments were utilized to evaluate the viability and proliferation of the cells, the histological appearance of the cartilage tissue and the
expression of speciﬁc cartilage markers by real-time polymerase chain reaction (PCR). In the 16 patients scheduled for ACI, the expanded
chondrocytes were used for chondrocyte implantation. In the other 4 patients, with lesion size!1.5 cm2, microfractures were created during
the initial arthroscopic step. As a control group, 7 patients with comparable osteochondral lesions underwent the same surgery, but received
chondrocytes harvested from the ipsilateral knee.
Results: According to the American Orthopaedic Foot and Ankle Scoring (AOFAS) system, patients in the experimental group had
a preoperative score of 54.2G 16 points and a postoperative one of 89G 9.6 points after a minimum follow-up time of 12 months
(P! 0.0005). The control group of patients had a preoperative score of 54.6G 11.7 points and a postoperative one of 90.2G 9.7 points at
a minimum follow-up time of 12 months (P! 0.0005). The clinical results of the two groups did not differ signiﬁcantly from each other.
Chondrocytes isolated from the detached fragments were highly viable, phenotypically stable, proliferated in culture and redifferentiated when
grown within the three-dimensional scaffold used for ACI. The morphological and molecular characteristics of the cartilage samples obtained
from the detached osteochondral fragments were similar to those of healthy hyaline articular cartilage.
Conclusions: The good results achieved with this strategy indicate that cells derived from the lesioned area may be useful in the treatment of
osteochondral defects of the talus.
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Key words: Osteochondral lesion, Autologous chondrocyte implantation, Osteochondral fragment.
OsteoArthritis and Cartilage (2005) 13, 601e607
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
doi:10.1016/j.joca.2005.02.010
International
Cartilage
Repair
SocietyIntroduction
Osteochondral lesions of the talus occur in approximately
6.5% of all ankle sprains, and in most cases following
inversion or eversion injuries of the ankle in young and
active people practicing sports1. The intrinsic inability of
articular cartilage to heal has been widely documented1,2
and this frequently necessitates surgical treatment3.
The repair tissue produced after implementing surgical
techniques such as chondral shaving or microfracturing
bears no resemblance to the original hyaline cartilage and
has poor mechanical properties4.
Brittberg et al.5 developed the autologous chondrocyte
implantation (ACI) technique, which permits the repair of
osteochondral lesions of the knee with a high percentage of
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Received 10 July 2004; revision accepted 12 February 2005.601hyaline-like cartilage tissue. Consequently, the ACI tech-
nique has been applied also to other joints, with satisfactory
results particularly in the ankle6,7. After a follow-up time of
more than 36 months in the latter, the clinical symptoms
were improved, and the histological analysis of biopsy
specimens revealed the formation of a repair cartilage with
typical hyaline-like features6. Although no complications
have been reported to date, one of the main problems of
this surgical strategy is related to the harvesting of the
cartilage slice from a healthy knee8.
In addition, it has been shown that knee cartilage differs
in composition from ankle cartilage, having a lower level of
proteoglycan synthesis and less active chondrocytes9.
These different characteristics might explain why the ankle
is less affected by progressive osteoarthritis than the
knee 9e11.
In order to avoid damage to a healthy knee due to the
harvesting of cartilage, and to utilize cartilage with the
appropriate characteristics for implantation in an ankle joint,
it may be reasonable to use the detached osteochondral
fragments for chondrocyte cultures.
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chondrocytes harvested from detached osteochondral frag-
ments, to proliferate and to serve as a viable source of cells
for ACI in the repair of ankle cartilage defects.
Patients and methods
PATIENTS
Human articular cartilage specimens were obtained from
the detached osteochondral fragments harvested from the
talus of 20 patients with osteochondral lesions of this joint.
The patients (11 males and 9 females) had a mean age of
30.5G 8 years. All of the lesions were of traumatic origin
and the mean time elapsing between the traumatic event
and surgery was 10 months (range: 6e20 months).
Preoperatively, all of the patients were evaluated
radiographically and clinically using the American Ortho-
paedic Foot and Ankle Scoring (AOFAS) system. Amongst
the inclusion criteria was a preoperative magnetic reso-
nance imaging (MRI) demonstrating an osteochondral
lesion and a detached osteochondral fragment. In all of
the patients scheduled for surgery, the fragment was
deﬁnable, still in situ with breached articular cartilage, and
classiﬁed as stage III according to the Dipaola arthroscopic
and MRI system12. As a control group, seven patients
(mean age: 26.8G 9 years) with similar characteristics and
who were affected by comparable osteochondral lesions
underwent the same surgery, but received chondrocytes
harvested from the ipsilateral knee.
The study design was approved by the Ethics Committee
at our Institution and informed consent was obtained from
all of the patients enrolled.
SURGICAL TECHNIQUE
In each of the 20 cases, an initial arthroscopy of the ankle
was performed, which permitted fragment removal, a mild
osteochondral shaving, and an accurate measurement of
the lesion size. According to the guidelines recently
proposed by the senior author (SG)8, the 16 patients with
a lesion size O1.5 cm2 were scheduled for ACI. In the
remaining 4 cases, with a lesion size !1.5 cm2, micro-
fracturing was performed during the initial arthroscopy.
Two parts of the detached fragments obtained from the
ankles were used. One sample was utilized for histology
and immunohistochemistry. The other sample was pro-
cessed for chondrocyte isolation, and the cells thereby
obtained were used for real-time polymerase chain reaction
(PCR) and the PicoGreen proliferation tests. As controls,
two biopsy samples of healthy cartilage were obtained from
the talus of two different male multiorgan donors, aged 20
and 37 years, who did not have a known history of arthritis
or related pathologies.
In the 16 patients scheduled for ACI, chondrocytes were
expanded from one of the fragments. These were implanted
30 days after harvesting using Hyalograft-C (Fab Advanced
Biopolymers, Abano Terme, Padova, Italy).
In the control group of 7 patients, cartilage was harvested
arthroscopically from the ipsilateral knee for cell culturing.
As in the experimental group, chondrocytes were expanded
and then implanted 30 days after harvesting using
Hyalograft-C.
In both groups, the second arthroscopic step was
performed using traditional anteromedial and anterolateral
arthroscopic accesses. The lesion was accurately shaved
and sized. Since none of the lesions had a depth O5 mm,no cancellous bone grafting was undertaken in this series13.
The chondrocytes were directly supported on an auto-
adhesive hyaluronan patch, which was arthroscopically
positioned over the lesion. Fibrin glue was used to improve
the stability of the transplanted matrix.
CHONDROCYTE ISOLATION AND GROWTH WITHIN
A THREE-DIMENSIONAL MATRIX
Chondrocytes were isolated enzymatically as previously
reported14. Fragments of the cartilaginous tissue were
cultured in Dulbecco’s modiﬁed Eagle’s medium [(DMEM)
Life Technologies, Paisley Scotland] containing 25 mM
HEPES (Sigma), penicillin [10,000 units/ml (Gibco)], strep-
tomycin [10,000 mg/ml (Gibco)], and gentamycin [50 mg/ml
(Biological Industries, Kibbutz Beth Haemek, Israel)].
Chondrocytes were isolated by sequential enzymatic
digestions at 37(C: 30 min with 0.1% hyaluronidase
(Sigma, St Louis, MO, USA), 1 h with 0.5% pronase
(Sigma) and 1 h with 0.2% collagenase (Sigma). The
isolated chondrocytes were ﬁltered successively through
sterile nylon meshes with pore diameters of 100 mm and
70 mm to remove cell and matrix debris. The ﬁltrate was
then centrifuged at 1800 rpm for 10 min. The pellet was
washed twice with DMEM supplemented with 10% fetal calf
serum (Biological Industries, Kibbutz Beth Haemek, Israel).
The cell number and viability were assessed by ital staining
with eosin. The cells were cultured under conventional
monolayer conditions at 37(C in a humidiﬁed atmosphere
containing 5% CO2 for about 3 weeks (3e4 passages). The
medium was changed twice a week.
To evaluate the chondrocyte redifferentiation process,
cells were seeded within the same hylauronan-based three-
dimensional biomaterial (Hyaff-11, Fidia) that was used for
ACI. To this end, 1! 106 conﬂuent cells were seeded
within a 1! 1 cm, 2-mm thick scaffold in a Petri dish
(Becton Dickinson, Plymouth, UK) containing 150 ml of
culture medium. The cells were allowed to adhere for 8 h at
37(C and before adding 2 ml of medium. The medium was
changed twice a week. The constructs were analyzed after
1, 7, 14 and 21 days. Prior to seeding within the biomaterial,
1! 106 cells were pelleted and utilized as a dedifferentiated
control (dedifs).
PROLIFERATION TEST
Cell proliferation rates were determined in triplicate at
different experimental times (1, 7, 14, 21 and 28 days) using
the PicoGreen dsDNA Quantitation kit (Molecular Probes,
Eugene, OR, USA) for the double-stranded DNA assay.
After collecting the supernatants, the adherent cells were
lysed with 100 ml of lysis buffer. PicoGreen working
solution (100 ml) was then added to each well. After
incubating for 5 min at ambient temperature, the ﬂuores-
cence of each sample was determined using a Spectramax
Gemini dual-scanning microplate spectroﬂuorimeter (Mo-
lecular Device, Sunnyvale, CA, USA) in the well-scan
mode, at an excitation wavelength of 480 nm, an emission
wavelength of 540 nm and a cut-off wavelength of 515 nm.
Fluorescence readings were converted to speciﬁc values
using a DNA standard curve.
QUANTIFICATION OF THE EXPRESSION CARTILAGE-SPECIFIC
MOLECULES BY REAL-TIME PCR
5! 105 cells that had been cultured in monolayers
immediately after isolation were pelleted and then lysed in
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Hyaff-11 scaffolds containing seeded chondrocytes were
collected at the different experimental times, placed in
Microcon-100 ﬁltration devices and then centrifuged at
1500! g for 5 min. The supernatant was discarded and the
cells lysed directly within the culture scaffolds by adding
0.5 ml of RNAWIZ reagent. Total RNA was isolated from
the samples using the single-step, guanidinium thio-
cyanateephenolechloroform method.
Complementary DNA was synthesized from 1 mg of total
RNA per sample at 42(C for 45 min using Moloney Murine
Leukemia Virus Reverse Transcriptase (Perkin Elmer,
Norwalk, CT, USA) and oligo-(dT) priming.
Real-time PCR was conducted in a LightCycler instru-
ment (Roche Molecular Biochemicals, Mannheim, Ger-
many) using the QuantiTect SYBR Green PCR kit
(Qiagen, GmbH, Germany) and the following protocol: initial
activation of HotStarTaq DNA polymerase at 94(C for
15 min, followed by 45 cycles of 15 s at 94(C, 20 s at
56e60(C and 10 s at 72(C. The increase in the PCR
product achieved after each ampliﬁcation cycle was
monitored as an increase in the ﬂuorescence generated
by the binding of the SYBR Green I dye to dsDNA. The
threshold cycle (CT) values (i.e., the cycle number required,
for the detected ﬂuorescence to attain a threshold value in
the range of the exponential ampliﬁcation) were determined
for each sample; the speciﬁcity of the amplicons was
conﬁrmed by a melting curve analysis and by agarose gel
electrophoresis. The sequences of the PCR primers for
aggrecan and the housekeeping gene glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), which was used as
an internal control, were in accordance with reference
standards15,16. PCR primers for type-I and type-II collagen
were designed using PRIMER 3 software17. Speciﬁc primer
pairs, PCR product length, annealing temperatures and the
relevant references are given in Table I.
Real-time PCR data were analyzed using the ‘‘compar-
ative CT method’’ described by Livak and Schmittgen
18. As
a relative quantiﬁcation method, it relates the PCR signal of
the target transcript in a group (or in different groups) to that
of a reference control group using the formula 2DDCT . The
DCT value represents, the mean difference between the CT
for each target gene (aggrecan, type-I and type-II colla-
gens) and that for the internal control gene (GAPDH). The
DDCT value for each speciﬁc gene represents the differ-
ence between the DCT for the different samples and the
control group. By deﬁnition DDCT equals zero and 2
0 equals
one for each control sample. Data pertaining to freshly
isolated chondrocytes from patients with osteochondritis
dissecans referred to those for cells obtained from the
healthy cartilage of a multiorgan donor. Data obtained fromchondrocytes of patients with osteochondritis dissecans
and grown within Hyaff-11 scaffolds for 1, 7, 14, and 21
days were referred to those for cells previously expanded in
monolayer cultures.
Using this method, the data are presented as differences
in gene expression (relative gene expression) normalized to
an endogenous reference gene and relative to a control
group.
HISTOLOGICAL ANALYSIS
Formalin-ﬁxed samples were decalciﬁed with Formical-
2000 (Decal Chemical, Congers, NY, USA) for 2 h at ambient
temperature. They were then dehydrated in a graded series
of ethanol and embedded in parafﬁn. Sections of 4-mm-thick
were prepared from the cartilage specimens, and the slides
were stored at ambient temperature until required for
analysis. Healthy human articular cartilage obtained from
a multiorgan donor was used as a control.
Tissue sections were stained either with 0.001% Fast
Green and 0.1% Safranin-O (Sigma) or with 1% Alcian Blue
8GX (Sigma).
IMMUNOHISTOCHEMISTRY
Immunohistochemical staining was performed using
antibodies against human type-I collagen (Chemicon In-
ternational, Temecula, CA, USA) and human type-II
collagen (Chemicon). Parafﬁn-embedded sections were
deparafﬁnized and rehydrated. To unmask the epitopes,
samples were treated with 0.1% hyaluronidase (Sigma) in
phosphate buffered saline (PBS) for 5 min at 37(C and then
incubated 30 min at ambient temperature in 1! PBS
containing either 5% normal rabbit serum (Dako, Carpin-
teria, CA, USA) or normal goat serum to prevent non-
speciﬁc binding. The slides were then incubated with the
primary antibodies against type-I collagen, or type-II
collagen (diluted 1:20 in 0.04 M Trizma Base Saline
(TBS), pH 7.6, containing 0.1% Triton X-100) for 1 h at
ambient temperature. The slides were washed three times
with 0.04 M TBS (pH 7.6) and then incubated with goat anti-
mouse and anti-rabbit immunoglobulins labeled with dex-
tranealkaline phosphatase (Envision, Dako) for 30 min at
ambient temperature. After three washes with 0.04 M TBS
(pH 7.6) the reaction product was visualized using the New
Fucsin Substrate System (Dako). Levamisole (5 mM,
Sigma) was used to block endogenous alkaline phospha-
tase activity. The slides were counterstained with hema-
toxylin, mounted in glycerol gel and stored at 4(C until
required for analysis. Negative controls were prepared by
omitting the primary antibody. All of the samples wereTable I
Real-time PCR primers description
RNA template Primer sequences Amplicon size (base pairs) Annealing temperature ((C) References*
Aggrecan 5#-TCG AGG ACA GCG AGG CC 85 60 13
3#-TCG AGG GTG TAG CGT GTA GAG A
Type-I collagen 5#-AGG TGC TGA TGG CTC TCC T 105 58
3#-GGA CCA CTT TCA CCC TTG T
Type-II collagen 5#-GAC AAT CTG GCT CCC AAC 257 58
3#-ACA GTC TTG CCC CAC TTA C
GAPDH 5#-TGG TAT CGT GGA AGG ACT CAT GAC 190 60 14
5#-ATG CCA GTG AGC TTC CCG TTC AGC
*Primer sequences were obtained from published references where indicated or designed using PRIMER 3 Software.
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Oberkochen, Germany).
Results
CHONDROCYTE ISOLATION AND PROLIFERATION
Chondrocytes isolated from the detached cartilage
samples were highly viable (99.9%) and their proliferation
rate was comparable to that of normal talar chondrocytes
(Fig. 1).
ANALYSIS OF THE EXPRESSION OF CARTILAGE-SPECIFIC
MOLECULES BY REAL-TIME PCR
Real-time PCR monitoring with the LightCycler and using
a ﬂuorescent dye permitted a rapid and sensitive detection
of the mRNAs for extracellular matrix molecules.
Relative gene expression levels calculated on the basis of
DCT values are shown in Fig. 2. The mRNA for collagen
type-II was higher in the experimental samples than in the
controls, whereas that both for collagen type-I and for
aggrecan was lower. The relative gene expression levels
calculated on the basis of DCT values for cells expanded in
monolayer cultures and then grown within the biomaterial for
different experimental times are presented in Fig. 3. The
expression of type-I collagen within the three-dimensional
scaffold increased until day 7 and then decreased up to day
21 [Fig. 3(A)]. The mRNA for type-II collagen was not
detected in monolayer cultures. After growing the cells within
the biomaterial, it increased only after 14 days for [Fig. 3(B)].
The expression of aggrecan did not follow a regular trend.
But after 21 days within the Hyaff-11 scaffolds, the level
was higher than in monolayer cultures [Fig. 3(C)].
HISTOLOGICAL AND IMMUNOHISTOCHEMICAL ANALYSES
The cartilage samples evaluated by staining with
Safranin-O and Alcian Blue manifested a histological
appearance that was typically hyaline. The extracellular
matrix contained a high concentration of proteoglycans, as
evidenced by its intense red coloration [Fig. 4(A,B)].
The immunohistochemical analysis for type-II collagen
revealed a positive signal within both the extracellular
matrix and many of the chondrocytes throughout the entire
Fig. 1. Proliferation of human chondrocytes isolated from the talar
cartilage of experimental patients and control donors at different
times. Data are expressed as mean cell number! 102G standard
deviation.thickness of the cartilage [Fig. 5(A)]. The immunohisto-
chemical analysis for type-I collagen was negative
[Fig. 5(B)].
CLINICAL
Neither subjective nor objective complications were
observed with the surgical procedure. The 16 experimental
patients had a preoperative AOFAS of 54.2G 16 points. At
a minimum postoperative follow-up of 12 months (range:
12e20 months), the score was 89G 9.6 points
(P! 0.0005). All of the patients expressed their satisfaction
with the results, and the ﬁve individuals who were followed
up for the longest time were able to resume their previous
sports activity level.
The control group of patients had a preoperative score of
54.6G 11.7 points and a postoperative one of 90.2G 9.7
points at a minimum follow-up time of 12 months
(P! 0.0005). These patients were likewise satisﬁed with
the results and they experienced no residual pain after the
harvesting of cartilage from the ipsilateral knee. A compar-
ison between the clinical results in each of the two groups
revealed no signiﬁcant difference.
Discussion
Acute displaced osteochondral lesions should be treated
by immobilization or open reduction and internal ﬁxation.
Unfortunately, the diagnosis is frequently missed. Conse-
quently, continuous motion across the fracture site leads to
avascular necrosis of the subchondral bone, thereby
rendering successful fragment ﬁxation increasingly difﬁ-
cult19. Because joint cartilage repairs but poorly, the
damage may be irreversible3.
ACI in the ankle joint has proved to be a reliable and
effective technique for repairing cartilage in young and
active patients, yielding good clinical results and permitting
the resumption of sports activities20. For ACI, trauma at the
donor site of the knee is low compared to that engendered
by the harvesting of plugs for a mosaicplasty, and no
complications have been reported to date. Nevertheless,
Fig. 2. Real-time PCR analysis with the LightCycler using samples
derived from experimental patients and control donors. The data
were analyzed using a relative quantiﬁcation method described in
the Patients and methods section. Experimental data are presented
as differences in gene expression (relative gene expression)
normalized to an endogenous reference gene (GAPDH) and
relative to a control group (chondrocytes derived from a multiorgan
donor).
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a disadvantage of the procedure8.
Sammarco et al.21 have reported that the removal from
the ankle of even the small amount of cartilage needed for
cell expansion may be potentially detrimental to the
functioning of this joint.
Fig. 3. Real-time PCR analysis with the LightCycler for type-I
collagen (A), type-II collagen (B) and aggrecan (C) using OCD
chondrocytes isolated from patients with osteochondritis dissecans
were expanded in monolayer cultures (dedifs) and then grown
within the three-dimensional biomaterial Hyaff-11 for 1, 7, 14 and
21 days. Data were analyzed using the relative quantiﬁcation
method described in the Patients and methods section. Experi-
mental data are presented as differences in gene expression
(relative gene expression) normalized to an endogenous reference
gene (GAPDH) and relative to dedifferentiated chondrocytes from
osteochondritis dissecans patients (dedifs).With a view to avoiding the harvesting of cartilage from
healthy non-weight bearing areas, Chaipinyo et al.22
evaluated the proliferative capacity of chondrocytes derived
from debrided damaged areas of the knee. They found that
these fragments could provide sufﬁcient cells for ACI.
Since interference with a healthy knee should be avoided
in surgical procedures relating to the ankle joint, the
possibility of using detached osteochondral fragments as
a convenient source of cells for ACI is worthy of
consideration.
In our patients, the osteochondral fragments were
removed from the affected ankle during an initial arthro-
scopic step, thereby permitting a direct intraoperative
evaluation of the lesions.
At a postoperative follow-up time of 12 months, the
clinical results in 16 patients were rated as good to excellent
Fig. 4. Histological appearance of the detached tissue from
a representative patient. (A) Safranin-O staining: The cartilage
has a typical hyaline-like appearance. (B) Alcian Blue staining: The
extracellular matrix is rich in proteoglycans, as evidenced by its
intense coloration (original magniﬁcation: !30).
606 S. Giannini et al.: Osteochondral fragments as a cell sourceand comparable to those previously achieved by ourselves
using the traditional Genzyme technique. In this earlier
study, an AOFAS of 91 points was achieved after a follow-
up of 24 months6. Furthermore, in the present study the
clinical results of the patients who had received cells did not
differ signiﬁcantly from those in the control group who had
received cells from the knee.
The viability of cells isolated from talus cartilage was very
high, and the expanded chondrocytes were able to re-
express their differentiated phenotype when seeded within
the three-dimensional scaffold used for transplantation. The
histochemical and immunohistochemical results also justify
the use of detached fragments for ACI. The cartilage
manifested typical hyaline features with respect to the
orientation of its collagen ﬁbers and the regular organization
of its cells, with a tangential orientation in the superﬁcial
layer and a columnar one in the deep zones. Real-time
PCR revealed the samples to be producing high levels of
the mRNA for type-II collagen and low levels of that for type-I
collagen.
Fig. 5. Immunostaining of the detached tissue from a representative
patient (original magniﬁcation:!30). (A) Immunostaining for type-II
collagen, revealing a positive signal within both the extracellular
matrix and many of the cells (see higher magniﬁcation [!250]
inset). (B) Immunostaining for type-I collagen is negative.These ﬁndings indicate that the cells were metabolically
active and that they were therefore adequately supplied
with nutrients and oxygen from the synovial ﬂuid present in
the detached cartilage fragments. Hence, these fragments
may serve as a convenient and useful source of cells for
ACI in the foot. Future comparative studies are needed to
validate the efﬁcacy of this technique.
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